Forvis Mazars Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Forvis Mazars Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Sell	4,277 -20	-0.5%	-$1.75K	0.01%	347
2026 Q1	$389K	Buy	4,297 +20	+0.5%	+$1.83K	0.01%	321
2025 Q4	$385K	Sell	4,277 -46	-1%	-$4.36K	0.01%	318
2025 Q3	$426K	Sell	4,323 -7	-0.2%	-$694	0.01%	309
2025 Q2	$395K	Buy	4,330 +14	+0.3%	+$1.35K	0.01%	325
2025 Q1	$488K	Buy	+4,316	New	+$462K	0.01%	286
2024 Q3	–	Sell	-4,488	Closed	-$487K	–	443
2024 Q2	$487K	Buy	+4,488	New	+$529K	0.01%	296

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Forvis Mazars Wealth Advisors's ZBH Position: Q2 2026 in Review

Forvis Mazars Wealth Advisors reduced its Zimmer Biomet (ZBH) stake by 0.47% in Q2 2026, selling an estimated $1.75K and leaving 4,277 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #347.

Forvis Mazars Wealth Advisors first reported a position in ZBH in Q2 2024 and has held it in 7 quarters since. The position peaked at $488K in Q1 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Forvis Mazars Wealth Advisors held 4,277 shares of Zimmer Biomet worth $368K as of Q2 2026.
Forvis Mazars Wealth Advisors sold 20 Zimmer Biomet shares in Q2 2026, an estimated $1.75K.
Zimmer Biomet made up 0.01% of Forvis Mazars Wealth Advisors's portfolio in Q2 2026, its #347 holding.
Forvis Mazars Wealth Advisors first reported a position in Zimmer Biomet in Q2 2024 and has held it in 7 quarters since.
Forvis Mazars Wealth Advisors's Zimmer Biomet position peaked at $488K in Q1 2025.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.